サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1727996

眼瞼手術の市場規模、シェア、動向分析レポート：手術タイプ別、最終用途別、地域別、セグメント予測、2025年～2030年

Eyelid Surgery Market Size, Share & Trends Analysis Report By Procedure Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.63円
眼瞼手術の市場規模、シェア、動向分析レポート：手術タイプ別、最終用途別、地域別、セグメント予測、2025年～2030年
出版日: 2025年04月17日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

眼瞼手術市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、眼瞼手術の世界市場規模は2030年までに101億5,000万米ドルに達すると予測され、予測期間中にCAGR 5.6％で拡大すると予測されています。

老年人口の増加に影響された目に関連する問題の増加は、市場成長に寄与する主な要因の1つです。国際美容整形外科学会（ISAPS）によると、2023年には世界全体で170万件以上の眼瞼手術が実施され、前年比24％の大幅増となりました。この人口動向は、眼瞼下垂や袋状眼瞼のような加齢に関連した状態に対処するための外科的介入の必要性が高まっていることを強調しています。

低侵襲手術への嗜好の高まりは、市場拡大を後押しする重要な要因です。回復期間の短縮、患者の快適性の向上、所要時間の短縮など、これらの技術に関連する利点は、予測期間を通じて高度な眼瞼手術技術の需要を促進すると予想されます。Rinsada社のeyelid retractorのような革新的な方法の開発に代表される、この分野における技術的進歩は、関連するリスクを軽減し、結果を改善することで、手術の魅力をさらに高めています。

市場の著名企業による最近の活動も業界の成長に寄与しています。特に、2024年7月、革新的な皮膚外科ソリューションを専門とする医療機器企業であるOsheru社は、400万米ドルを超える資金調達ラウンドの成功を発表しました。この投資は、眼瞼形成術に関連する課題に対処するために特別に設計された医療機器であるZiplyftの開発と商業化を加速させることを目的としており、業界内で継続的な革新と投資が行われていることを示しています。

眼瞼手術市場レポートハイライト

  • 北米は全市場シェアの37.0％以上を占め、全地域の中で最も優勢です。これは、高齢者人口の増加や低侵襲技術などの要因によるものです。
  • 上眼瞼手術は、目元の治療と美容に顕著に応用されているため、2024年には55.0％以上のシェアを占め、手技分野では優位を占めています。
  • クリニックとスパセンターセグメントは、医療ツーリズムの増加と先端技術の地理的普及により、2024年に65.0％以上の最大市場シェアを占めました。
  • 高度な医療ツールや技術の採用が増加し、市場の需要を押し上げると予想されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 眼瞼の手術市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 眼瞼の手術市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 眼瞼の手術：手術タイプ別　推定・動向分析

  • 手術タイプ別　ダッシュボード
  • 眼瞼の手術市場：手術タイプ別　変動分析
  • 世界の眼瞼手術市場規模と動向分析（手術別、2018～2030年）
  • 上眼瞼の手術
    • 2018年から2030年までの市場推計・予測
  • 下眼瞼の手術
    • 2018年から2030年までの市場推計・予測

第5章 眼瞼の手術市場：最終用途別　推定・動向分析

  • 最終用途別　ダッシュボード
  • 眼瞼の手術市場：最終用途別　変動分析
  • 世界の眼瞼手術市場規模と動向分析（最終用途別、2018～2030年）
  • 病院
  • クリニックとスパセンター

第6章 眼瞼の手術市場：地域別　推定・動向分析

  • 地域別　市場ダッシュボード
  • 地域別　市場シェア分析、2024年および2030年
  • 地域別　眼瞼手術市場：主なポイント
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • Key company heat map analysis, 2024
  • 企業プロファイル
    • Integra LifeSciences Corporation
    • Stanford Health Care
    • Surgical Holdings
    • Stryker
    • American Society of Plastic Surgeons
    • London Bridge Plastic Surgery
    • Montenegro Clinic of Plastic Surgery
    • Shoyukai Medical Association
図表

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global eyelid surgery market, by region, 2018 - 2030 (USD Million)
  • Table 4. Global eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 5. Global eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 6. North America eyelid surgery market, by country, 2018 - 2030 (USD Million)
  • Table 7. North America eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 8. North America eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 9. U.S. eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 10. U.S. Eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 11. Canada eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 12. Canada eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 13. Mexico eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 14. Mexico eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 15. Europe eyelid surgery market, by country, 2018 - 2030 (USD Million)
  • Table 16. Europe eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 17. Europe eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 18. UK eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 19. UK Eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 20. Germany eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 21. Germany eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 22. France eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 23. France Eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 24. Italy eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 25. Italy eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 26. Spain eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 27. Spain eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 28. Norway eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 29. Norway Eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 30. Denmark eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 31. Denmark eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 32. Sweden eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 33. Sweden eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific eyelid surgery market, by country, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 36. Asia Pacific eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 37. Japan eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 38. Japan eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 39. China eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 40. China eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 41. India eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 42. India eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 43. Australia eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 44. Australia eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 45. South Korea eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 46. South Korea eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 47. Thailand eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 48. Thailand eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 49. Latin America eyelid surgery market, by country, 2018 - 2030 (USD Million)
  • Table 50. Latin America eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 51. Latin America eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 52. Brazil eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 53. Brazil eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 54. Argentina eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 55. Argentina eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa Eyelid surgery market, by country, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 58. Middle East & Africa eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 59. South Africa eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 60. South Africa eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 63. UAE eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 64. UAE eyelid surgery market, by end use, 2018 - 2030 (USD Million)
  • Table 65. Kuwait eyelid surgery market, by procedure type, 2018 - 2030 (USD Million)
  • Table 66. Kuwait eyelid surgery market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Eyelid surgery market segmentation
  • Fig. 2 Eyelid surgery market segmentation
  • Fig. 3 Market research process
  • Fig. 4 Data triangulation techniques
  • Fig. 5 Primary research pattern
  • Fig. 6 Market research approaches
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Drug class and route of administration outlook (USD Million)
  • Fig. 11 Distribution channel outlook
  • Fig. 12 Competitive landscape
  • Fig. 13 Eyelid surgery market dynamics
  • Fig. 14 Eyelid surgery market: Porter's five forces analysis
  • Fig. 15 Eyelid surgery market: PESTLE analysis
  • Fig. 16 Eyelid surgery market: Procedure type segment dashboard
  • Fig. 17 Eyelid surgery market: Procedure type market share analysis, 2024 & 2030
  • Fig. 18 Upper eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 19 Lower eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 20 Eyelid surgery market: End use segment dashboard
  • Fig. 21 Eyelid surgery market: End use market share analysis, 2024 & 2030
  • Fig. 22 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 23 Clinics & spa centers market, 2018 - 2030 (USD Million)
  • Fig. 24 Eyelid surgery market revenue, by region
  • Fig. 25 Regional marketplace: Key takeaways
  • Fig. 26 Regional marketplace: Key takeaways
  • Fig. 27 North America eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 28 U.S. country dynamics
  • Fig. 29 U.S. eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 30 Canada country dynamics
  • Fig. 31 Canada eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 32 Mexico country dynamics
  • Fig. 33 Mexico eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 34 Europe eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 35 UK country dynamics
  • Fig. 36 UK eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 37 Germany country dynamics
  • Fig. 38 Germany eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 39 France country dynamics
  • Fig. 40 France eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 41 Italy country dynamics
  • Fig. 42 Italy eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 43 Spain country dynamics
  • Fig. 44 Spain eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 45 Norway country dynamics
  • Fig. 46 Norway eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 47 Sweden country dynamics
  • Fig. 48 Sweden eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark country dynamics
  • Fig. 50 Denmark eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 52 Japan country dynamics
  • Fig. 53 Japan eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 54 China country dynamics
  • Fig. 55 China eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 56 India country dynamics
  • Fig. 57 India eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 58 Australia country dynamics
  • Fig. 59 Australia eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 60 South Korea country dynamics
  • Fig. 61 South Korea eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 62 Thailand country dynamics
  • Fig. 63 Thailand eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 64 Latin America eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 65 Brazil country dynamics
  • Fig. 66 Brazil eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 67 Argentina country dynamics
  • Fig. 68 Argentina eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 69 MEA eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 70 South Africa country dynamics
  • Fig. 71 South Africa eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 72 Saudi Arabia country dynamics
  • Fig. 73 Saudi Arabia eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 74 UAE country dynamics
  • Fig. 75 UAE eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 76 Kuwait country dynamics
  • Fig. 77 Kuwait eyelid surgery market, 2018 - 2030 (USD Million)
  • Fig. 78 Company categorization
  • Fig. 79 Company market position analysis
  • Fig. 80 Strategic framework
目次
Product Code: GVR-3-68038-516-8

Eyelid Surgery Market Growth & Trends:

The global eyelid surgery market size is anticipated to reach USD 10.15 billion by 2030 and is projected to expand at a CAGR of 5.6% during the forecast period, according to a new report by Grand View Research, Inc. The rising eye-related problems influenced by the growing geriatric population is one of the major factors contributing to the market growth. According to the International Society of Aesthetic Plastic Surgery (ISAPS), over 1.7 million eyelid surgeries were performed globally in 2023, marking a substantial 24% increase compared to the preceding year. This demographic trend underscores the rising need for surgical interventions to address age-related conditions such as ptosis and baggy eyelids.

The escalating preference for minimally invasive procedures is a key factor propelling market expansion. The advantages associated with these techniques, including faster recovery periods, enhanced patient comfort, and shorter turnaround times, are anticipated to fuel demand for advanced eyelid surgery techniques throughout the forecast period. Technological advancements in the field, exemplified by the development of innovative methods like Rinsada's eyelid retractor, have further augmented the procedure's appeal by reducing associated risks and improving outcomes.

Recent activities among prominent companies in the market are also contributing to industry growth. Notably, in July 2024, Osheru, a medical device company specializing in innovative skin surgery solutions, announced the successful completion of a funding round that garnered over USD 4.0 million. This investment intended to accelerate the development and commercialization of Ziplyft, a medical device specifically designed to address challenges associated with blepharoplasty, indicating ongoing innovation and investment within the industry.

Eyelid Surgery Market Report Highlights:

  • North America is the most dominant among all regions, with more than 37.0% of the total market share, driven by factors such as increase in geriatric population and minimally invasive technology
  • Upper eyelid surgery dominated the procedure segment with more than 55.0% share in 2024 owing to its prominent application in curing and beautifying eyes
  • The clinics and spa centers segment held the largest market share of over 65.0% in 2024 due to the increase in medical tourism and the geographical proliferation of advanced technology
  • Increasing adoption of advanced medical tools and techniques is anticipated to boost market demand

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Procedure
    • 1.2.2. End Use
    • 1.2.3. Regional Scope
    • 1.2.4. Estimates and Forecasts Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Procedure outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Eyelid Surgery Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Eyelid Surgery Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Eyelid Surgery: Procedure Estimates & Trend Analysis

  • 4.1. Procedure Segment Dashboard
  • 4.2. Eyelid Surgery Market: Procedure Movement Analysis
  • 4.3. Global Eyelid Surgery Market Size & Trend Analysis, by Procedure, 2018 to 2030 (USD Million)
  • 4.4. Upper Eyelid Surgery
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Lower Eyelid Surgery
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Eyelid Surgery Market: End Use Estimates & Trend Analysis

  • 5.2. Application Segment Dashboard
  • 5.3. Eyelid Surgery Market: Application Movement Analysis
  • 5.4. Global Eyelid Surgery Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.5. Hospitals
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Clinic and Spa Centers
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Eyelid Surgery Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. Eyelid Surgery Market by Region: Key Takeaways
  • 6.4. North America
    • 6.4.1. U.S.
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Canada
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Mexico
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. UK
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Germany
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. France
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Spain
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Denmark
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.7. Sweden
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.8. Norway
      • 6.5.8.1. Key country dynamics
      • 6.5.8.2. Regulatory framework/ reimbursement structure
      • 6.5.8.3. Competitive scenario
      • 6.5.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. China
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. India
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Australia
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Thailand
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Brazil
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Argentina
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Middle East & Africa
    • 6.8.1. South Africa
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Saudi Arabia
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. UAE
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.4. Kuwait
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Regulatory framework/ reimbursement structure
      • 6.8.4.3. Competitive scenario
      • 6.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company heat map analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Integra LifeSciences Corporation
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Stanford Health Care
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Surgical Holdings
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Stryker
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. American Society of Plastic Surgeons
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. London Bridge Plastic Surgery
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Montenegro Clinic of Plastic Surgery
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Shoyukai Medical Association
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives